Standards and perspectives in the diagnosis and treatment of pancreatic adenocarcinoma.
Despite certain advances, the overall prognosis for pancreatic carcinoma has remained extremely dismal. Even now, not more than 5% of all patients diagnosed as having pancreatic carcinoma survive 5 years. With this background, the standards and new developments for this entity are discussed.
Sulkowski
U
U
Department of General Surgery, Münster University Hospitals, Germany.
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000628:therapy*